• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/5/21 1:49:41 PM ET
    $PAIC
    Business Services
    Finance
    Get the next $PAIC alert in real time by email
    SC 13G/A 1 formsc13ga.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. __1____)*

     

    Petra Acquisition, Inc.

     

    (Name of Issuer)

     

    Common Stock

     

    (Title of Class of Securities)

     

    716421201

     

    (CUSIP Number)

     

    December 31, 2020

     

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    [  ] Rule 13d-1(b)

    [X] Rule 13d-1(c)

    [  ] Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     
     

     

    CUSIP No. 716421201

     

    1.  

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Boothbay Absolute Return Strategies LP

       
    2.  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (see instructions)

    (a) [  ]

    (b) [X]

       
    3.  

    SEC USE ONLY

     

       
    4.  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

       

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5.  

    SOLE VOTING POWER

     

    0

      6.  

    SHARED VOTING POWER

     

    0

      7.  

    SOLE DISPOSITIVE POWER

     

    0

      8.   SHARED DISPOSITIVE POWER
     
    0

    9.  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

       
    10.  

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (see instructions) [  ]

     

       
    11.  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0%

       
    12.  

    TYPE OF REPORTING PERSON (see instructions)

     

    PN

       

     

     
     

     

    CUSIP No. 716421201

     

    1.   NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    Boothbay Fund Management, LLC
       
    2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a) [  ]
    (b) [X]
       
    3.   SEC USE ONLY
     
       
    4.   CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
       

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH     5.   SOLE VOTING POWER
     
    0
        6.   SHARED VOTING POWER
     
    0
        7.   SOLE DISPOSITIVE POWER
     
    0
        8.   SHARED DISPOSITIVE POWER
     
    0

    9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    0
       
    10.  

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions) [  ]

     

       
    11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    0%
       
    12.   TYPE OF REPORTING PERSON (see instructions)

    IA, OO
       

     

     
     

     

    CUSIP No. 716421201

     

    1.   NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    Ari Glass
       
    2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a) [  ]
    (b) [X]
       
    3.   SEC USE ONLY
     
       
    4.   CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
       

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH     5.   SOLE VOTING POWER
     
    0
        6.   SHARED VOTING POWER
     
    0
        7.   SOLE DISPOSITIVE POWER
     
    0
        8.   SHARED DISPOSITIVE POWER
     
    0

    9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    0
       
    10.  

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions) [  ]

     

       
    11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    0%
       
    12.   TYPE OF REPORTING PERSON (see instructions)

    IN, HC
       

     

     
     

     

    Item 1.

     

      (a) Name of Issuer
    Petra Acquisition, Inc. (the “Issuer”)
         
      (b)

    Address of Issuer’s Principal Executive Offices

    5 West 21st Street

    New York, NY 10010

     

    Item 2.

     

      (a)

    Name of Person Filing:
    Boothbay Absolute Return Strategies LP*

    Boothbay Fund Management, LLC*

    Ari Glass*

         
      (b)

    Address of the Principal Office or, if none, residence
    140 East 45th Street, 14th Floor

    New York, NY 10017

         
      (c)

    Citizenship
    Boothbay Absolute Return Strategies LP – Delaware

    Boothbay Fund Management, LLC – Delaware

    Ari Glass – United States

         
      (d) Title of Class of Securities
    Common Stock
         
      (e) CUSIP Number
    716421201
         

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: N/A

     

    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

      (a)  

    Amount beneficially owned:

     

    Boothbay Absolute Return Strategies LP – 0

    Boothbay Fund Management, LLC – 0

    Ari Glass – 0

             
      (b)  

    Percent of class:

    Boothbay Absolute Return Strategies LP – 0%

    Boothbay Fund Management, LLC – 0%

    Ari Glass – 0%

     

     
     

     

      (c)   Number of shares as to which the person has:
             
          (i)

    Sole power to vote or to direct the vote

    Boothbay Absolute Return Strategies LP – 0

    Boothbay Fund Management, LLC – 0

    Ari Glass – 0

             
          (ii)

    Shared power to vote or to direct the vote

    Boothbay Absolute Return Strategies LP – 0

    Boothbay Fund Management, LLC – 0

    Ari Glass – 0

             
          (iii)

    Sole power to dispose or to direct the disposition of

    Boothbay Absolute Return Strategies LP – 0

    Boothbay Fund Management, LLC – 0

    Ari Glass – 0

             
          (iv)

    Shared power to dispose or to direct the disposition of

    Boothbay Absolute Return Strategies LP – 0

    Boothbay Fund Management, LLC – 0

    Ari Glass – 0

     

    Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

     

     
     

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

     

    [X]

     

    Instruction. Dissolution of a group requires a response to this item.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    N/A

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    N/A

     

    Item 8. Identification and Classification of Members of the Group.

     

    N/A

     

    Item 9. Notice of Dissolution of Group.

     

    N/A

     

    Item 10. Certification.

     

     

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     
     

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 5, 2021

     

      Boothbay Absolute Return Strategies LP
         
      By: Boothbay Fund Management, LLC, its investment manager
         
      By: /s/ Ari Glass
        Ari Glass, Managing Member
         
      Boothbay Fund Management, LLC
         
      By: /s/ Ari Glass
        Ari Glass, Managing Member
         
      Ari Glass
         
      By: /s/ Ari Glass
        Individually

     

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

     

    Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.

     

    Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

     

     
     

     

    JOINT FILING STATEMENT

    PURSUANT TO RULE 13D-1(K)(1)

     

    The undersigned hereby consent and agree to the joint filing of Schedule 13G Amendment No. 1 under the Securities Exchange Act of 1934, as amended, with respect to the Shares of Petra Acquisition, Inc., together with any or all amendments thereto, when and if required. The parties hereto further consent and agree to file this Joint Filing Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule13G.

     

    This Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.

     

    Dated: February 5, 2021

     

      Boothbay Absolute Return Strategies LP
         
      By: Boothbay Fund Management, LLC, its investment manager
         
      By: /s/ Ari Glass
        Ari Glass, Managing Member
         
      Boothbay Fund Management, LLC
         
      By: /s/ Ari Glass
        Ari Glass, Managing Member
         
      Ari Glass
         
      By: /s/ Ari Glass
        Individually

     

     

     

    Get the next $PAIC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $PAIC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PAIC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Feis Lawrence disposed of $7,465,890 worth of shares (731,950 units at $10.20)

      4 - Petra Acquisition Inc. (0001810560) (Issuer)

      1/11/22 3:59:54 PM ET
      $PAIC
      Business Services
      Finance
    • SEC Form 3: New insider Feis Lawrence claimed ownership of 746,491 shares

      3 - Petra Acquisition Inc. (0001810560) (Issuer)

      11/2/21 2:39:14 PM ET
      $PAIC
      Business Services
      Finance
    • SEC Form 4: Glazer Capital, Llc sold $6,597,824 worth of Common stock (654,546 units at $10.08)

      4 - Petra Acquisition Inc. (0001810560) (Issuer)

      9/23/21 4:21:06 PM ET
      $PAIC
      Business Services
      Finance

    $PAIC
    SEC Filings

    See more
    • Petra Acquisition, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Change in Shell Company Status

      8-K - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)

      1/14/22 4:28:56 PM ET
      $PAIC
      Business Services
      Finance
    • Petra Acquisition, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)

      1/13/22 3:53:16 PM ET
      $PAIC
      Business Services
      Finance
    • Petra Acquisition, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)

      1/12/22 4:49:37 PM ET
      $PAIC
      Business Services
      Finance

    $PAIC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections

      - Phase 2b study will investigate the efficacy of REVTx-99 on viral load and patient-reported flu symptoms- - Top-line data anticipated in the second quarter of 2022 - SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (Revelation), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease, announced today it has received approval from the Federal Agency for Medicines and Health Products (FAMHP) and the local Committee of Medical Ethics in Belgium to conduct a Phase 2b influenza viral challenge study. The Phase 2b, randomized, double-blind, influenza viral challenge study (RV

      9/28/21 9:00:00 AM ET
      $PAIC
      Business Services
      Finance
    • Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.

      Revelation's lead product candidate REVTx-99 has potential, through innate immune system stimulation, to broadly prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2 including its variants, influenza A and B, parainfluenza, rhinovirus, and respiratory syncytial virus (RSV) Combined company expected to have a post-transaction pro forma total enterprise value of approximately $128 million Merger expected to close in Q4 2021, and combined company will be listed on NASDAQ under the ticker symbol "REVB" Revelation and Petra Acquisition will host a joint investor conference call and webcast to discuss the proposed transaction on August 30, 2021 at 4:30 p.m

      8/30/21 6:00:00 AM ET
      $PAIC
      Business Services
      Finance
    • PETRA ACQUISITION, INC. RECEIVES EXPECTED NASDAQ NOTIFICATION REGARDING DELAYED FORM 10-Q

      New York, NY, June 01, 2021 (GLOBE NEWSWIRE) -- Petra Acquisition, Inc. (NASDAQ:PAIC) (the "Company"), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, announced that on May 28, 2021, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") advising that because the Company failed to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021 (the "Form 10-Q"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"). Nasdaq has inform

      6/1/21 4:30:00 PM ET
      $PAIC
      Business Services
      Finance

    $PAIC
    Financials

    Live finance-specific insights

    See more
    • Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.

      Revelation's lead product candidate REVTx-99 has potential, through innate immune system stimulation, to broadly prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2 including its variants, influenza A and B, parainfluenza, rhinovirus, and respiratory syncytial virus (RSV) Combined company expected to have a post-transaction pro forma total enterprise value of approximately $128 million Merger expected to close in Q4 2021, and combined company will be listed on NASDAQ under the ticker symbol "REVB" Revelation and Petra Acquisition will host a joint investor conference call and webcast to discuss the proposed transaction on August 30, 2021 at 4:30 p.m

      8/30/21 6:00:00 AM ET
      $PAIC
      Business Services
      Finance

    $PAIC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Petra Acquisition, Inc. (Amendment)

      SC 13G/A - Petra Acquisition Inc. (0001810560) (Subject)

      1/11/22 3:34:57 PM ET
      $PAIC
      Business Services
      Finance
    • SEC Form SC 13G/A filed by Petra Acquisition, Inc. (Amendment)

      SC 13G/A - Petra Acquisition Inc. (0001810560) (Subject)

      10/12/21 4:02:40 PM ET
      $PAIC
      Business Services
      Finance
    • SEC Form SC 13G/A filed by Petra Acquisition, Inc. (Amendment)

      SC 13G/A - Petra Acquisition Inc. (0001810560) (Subject)

      10/12/21 10:33:03 AM ET
      $PAIC
      Business Services
      Finance